T1	Participants 181 203	healthy adult subjects
T2	Participants 607 653	Forty-two healthy adult subjects were enrolled
T3	Participants 1888 1944	clinical evaluation in multiple PI-experienced patients.
T4	Participants 27 63	evaluation of high-dose combinations
